NewsAmrutanjan Health Care Approves Revised Second Phase ESOP 2 Under Employee Stock Option Scheme 2020Amrutanjan Health Care Approves Revised Second Phase ESOP 2 Under Employee Stock Option Scheme 2020
Amrutanjan Health Care Limited's Board approved the revised Second Phase ESOP 2 under its Employee Stock Option Scheme 2020 on May 8, 2026, covering 2,00,000 equity shares for 44 top and middle management employees. The grant price was set at Rs. 502.00, derived after applying a 10% discount to the closing NSE market price of Rs. 558.00 on May 7, 2026, with vesting conditions tied to sales targets across FY27 to FY31 and a last exercise window of October 2031.
*this image is generated using AI for illustrative purposes only.
Amrutanjan Health Care Limited's Board of Directors, at its meeting held on May 8, 2026, approved the rolling out of the revised Second Phase 'ESOP 2' under the existing Amrutanjan Health Care Limited – Employees Stock Option Scheme 2020. The approval was granted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was based on the recommendation of the Compensation Committee. The scheme is designed to provide eligible employees an opportunity to participate in, contribute to, and gain from the company's future growth.
Key Details of the Revised Second Phase ESOP 2
The revised Second Phase covers 44 employees at the top and middle management level. The following table summarises the key parameters of the scheme as disclosed by the company:
| Parameter: | Details |
|---|---|
| Scheme Name: | Amrutanjan Health Care Limited – Employees Stock Option Scheme 2020 |
| Phase: | Revised Second Phase (ESOP 2) |
| Number of Eligible Employees: | 44 employees (top and middle management) |
| Total Shares Covered: | 2,00,000 equity shares |
| Vesting Period: | Spread across 5 years (FY27 to FY31) |
| Vesting Condition: | Achievement of 2 slabs of sales target for each financial year |
| Special Allocation: | 10% of allocation for first-time grantees without any vesting condition at the end of one year |
| Closing NSE Market Price (May 7, 2026): | Rs. 558.00 |
| Discount: | 10% – Rs. 55.80 |
| Grant Price: | Rs. 502.00 |
| Last Exercise Window: | October 2031 |
| SEBI Compliance: | Yes – SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 |
Grant Price and Pricing Formula
The grant price for the options has been determined based on the closing market price of Amrutanjan Health Care Limited's equity shares on the National Stock Exchange as on May 7, 2026. A 10% discount has been applied to arrive at the final grant price, as detailed below:
- Closing NSE Market Price: Rs. 558.00
- Discount (10%): Rs. 55.80
- Grant Price: Rs. 502.00
The grant price is rounded off to the nearest rupee as per the pricing formula approved by the Board.
Scheme Implementation and Significant Terms
The scheme will be implemented through the ESOP Trust managed by Surana & Surana, who serve as the ESOP Trustees. Key operational terms of the scheme include:
- Shares will be acquired from the secondary market for allocations during the different vesting periods.
- The Nomination and Remuneration Committee (NRC) and the Board may exercise powers under Clause 9.2 of the ESOP Scheme, 2020 to revise vesting conditions from time to time.
- The Compensation Committee retains the authority to make modifications, changes, variations, alterations, or revisions to the plan as it deems fit, in its sole and absolute discretion, provided such changes are not unfavourable or prejudicial to allottees, and are in conformity with the Companies Act, 2013, the Memorandum and Articles of Association of the company, SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, and other applicable laws.
Regulatory Disclosure
The intimation was filed by Gagan Preet Singh, General Manager – Legal, Company Secretary & Compliance Officer of Amrutanjan Health Care Limited, in accordance with Regulation 30 of SEBI LODR read with SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023. The company is headquartered at 103, (Old No. 42-45), Luz Church Road, Mylapore, Chennai – 600 004, Tamil Nadu, India.
Historical Stock Returns for Amrutanjan Health Care
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.70% | -3.97% | +7.18% | -22.47% | -19.26% | -12.84% |
How might the sales-target-linked vesting conditions impact employee retention and performance if Amrutanjan Health Care misses its revenue growth targets in any of the FY27–FY31 periods?
Given that shares will be acquired from the secondary market, what potential upward pressure could the ESOP Trust's buying activity exert on Amrutanjan Health Care's stock price over the five-year vesting window?
How does Amrutanjan Health Care's ESOP participation rate of 44 employees compare to industry peers in the FMCG and healthcare sector, and could this signal plans to expand the scheme to broader employee levels in future phases?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
